TABLE 4.
P value | ||||
---|---|---|---|---|
Graded Exercise Group |
Graded Exposure Group |
Interaction† | Time‡ | |
Primary outcome measures | ||||
Pain intensity (0–10) | .81 | <01 | ||
Pretreatment§ | 6.3 ± 1.2 | 4.6 ± 2.1 | ||
Posttreatment§ | 4.1 ± 2.5 | 2.6 ± 1.9 | ||
Pain related disability (0–100) | .44 | <01 | ||
Pretreatment | 56.0 ± 13.9 | 43.3 ± 12.5 | ||
Posttreatment | 470 ± 171 | 38.0 ± 14.1 | ||
Psychologic measures | ||||
Fear of pain (30–150) | .25 | .33 | ||
Pretreatment | 63.3 ± 18.1 | 80.6 ± 22.0 | ||
Posttreatment | 64.4 ± 22.0 | 677 ± 28.9 | ||
Fear-avoidance beliefs, physical activity (0–24) | .39 | .08 | ||
Pretreatment | 15.8 ± 6.2 | 171 ± 5.6 | ||
Posttreatment | 14.4 ± 75 | 13.3 ± 6.9 | ||
Fear-avoidance beliefs, work (0–42) | .88 | .78 | ||
Pretreatment | 33.7 ± 6.8 | 30.6 ± 12.3 | ||
Posttreatment | 32.6 ± 6.9 | 30.2 ± 10.3 | ||
Kinesiophobia (13–52) | .60 | .10 | ||
Pretreatment | 30.0 ± 5.8 | 32.1 ± 7.0 | ||
Post-treatment | 26.0 ± 8.7 | 30.0 ± 9.1 | ||
Pain catastrophizing (0–36) Pretreatment | 18.7 ± 10.9 | 14.8 ± 10.0 | .70 | <.01 |
Posttreatment | 76 ± 8.9 | 5.9 ± 6.1 | ||
Depressive symptoms (0–63) | .92 | <.01 | ||
Pretreatment | 23.3 ± 10.2 | 28.1 ± 15.7 | ||
Posttreatment | 6.5 ± 6.0 | 11.9 ± 10.9 |
All values reported as mean ± SD unless otherwise indicated.
Interaction refers to the P value for the group-by-time effect.
Time refers to the P value for the pretreatment-posttreatment main effect.
Indicates significant group differences (P<.05).